Literature DB >> 28987667

Shear wave elastography findings of de Quervain tenosynovitis.

Rustu Turkay1, Ercan Inci2, Banu Aydeniz3, Meltem Vural4.   

Abstract

OBJECTIVE: Our aim was to evaluate the feasibility of using shear wave elastography (SWE) to assess first extensor compartment tendons rigidity and its alterations with tenosynovitis.
MATERIALS AND METHODS: We performed B-mode ultrasound and SWE to total number of 80 participants. All participants were evaluated clinically to call the diagnosis of de Quervain tenosynovitis or to rule out the diagnosis. We composed 2 groups. Group 1 included 40 healthy volunteers (33 females and 7 male participants with ages ranging from 24 to 60 years, median age was 37.5 years) and group 2 had 40 de Quervain patients (32 females and 8 male patients with ages ranging from 25 to 51 years, median age was 34 years). SWE measurements were repeated 3 times and arithmetic average was used for the final SWE value.
RESULTS: The median SWE value of healthy group (group 1) was 72kPa and the de Quervain patient group (group 2) was 29kPa. Two groups demonstrated statistically significant difference (p<0.001). The ROC curve analysis was performed and the SWE value of 40.5kPA was calculated as a cut-off value for the diagnosis of de Quervain tenosynovitis with 95% specificity and 85% sensitivity.
CONCLUSION: SWE modality can provide useful data regarding de Quervain tenosynovitis.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  De quarvain tenosinovitis; Elastography; First extensor compartment; Shear wave; Tendons

Mesh:

Year:  2017        PMID: 28987667     DOI: 10.1016/j.ejrad.2017.08.011

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  1 in total

1.  Feasibility Trial to Evaluate Tendon Stiffness Obtained from Shear Wave Elastography Imaging as a Biomarker of Aromatase Inhibitor-Induced Arthralgias.

Authors:  Jessica A Martinez; Mihra S Taljanovic; Andres A Nuncio Zuniga; Betsy C Wertheim; Denise J Roe; Sima Ehsani; Sao Jiralerspong; Jennifer Segar; Pavani Chalasani
Journal:  J Clin Med       Date:  2022-02-18       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.